IHDSC Seed Awards to Support Interdisciplinary Research

Sponsor:

NYU’s Institute of Human Development and Social Change (IHDSC)

Deadline:

December 8, 2017 at 5PM

Summary:

The IHDSC seed program provides support for faculty members to jumpstart new programs of multidisciplinary research. The University recognizes that scholars who take up the challenge of conducting interdisciplinary research often need support to conduct preliminary research before they can develop larger proposals for funding. As such, IHDSC is committed to supporting faculty with funding for new projects that bridge multiple domains of expertise while furthering the mission of IHDSC. This year, we are also pleased to include a priority for projects that involve collaboration with community based organizations or government agency partners.

Proposed research projects must fit within the research focus areas of the Institute, which include the following:

  • Poverty and inequality
  • Education and child development
  • Health and wellbeing
  • Social policy in local, national, and global contexts

Projects should focus on basic change processes in human development, and how these processes are affected by educational, social, economic, historical, political, and cultural contexts. Projects may also explore how human development processes might be altered by intentional change strategies, interventions, or policy.

Research projects that also include one or more of the following components will be given priority:

  • Projects led by junior faculty / junior investigators
  • Projects led by faculty or investigators that are new to IHDSC and/or NYU
  • Projects led by new teams (i.e. teams of investigators that haven’t collaborated in the past)
  • Projects that include collaboration with an external partner focused on policy or practice (community based organizations, non-profit organizations, NGOs, or government agencies)

Eligibility:

  1. All full-time, tenure-track faculty members are eligible to apply. Research Scientists who have PI status are also eligible to apply.
  2. At least one of the lead investigators must be from one of the core schools affiliated with IHDSC: the Steinhardt School of Culture, Education, and Human Development, the Faculty of Arts and Science, or the Robert F. Wagner School of Public Service
  3. Proposals must draw upon theoretical and analytic approaches from multiple disciplines.
  4. A letter with the chair’s signature or review/approval from OSP is NOT required.
  5. Previous IHDSC seed grant awardees cannot reapply for funding for the same project.

*Please note that seed award recipients will be required to submit proposals through IHDSC, or as collaborative proposals through IHDSC and another unit at NYU.*

Available Funding:

Awards typically range from $5,000-$15,000, and will not exceed $20,000. Award size depends on the proposed scope of work. Funds are not permitted for faculty support. Budgeted expenses may include wages for student assistants, fringe benefits, travel related to data collection, fieldwork expenses, computer time, consultation, hourly assistance, etc.

Link to Full RFP:

http://steinhardt.nyu.edu/scmsAdmin/media/users/eez206/IHDSC_Fall2017_SeedGrants_CFA.pdf

Research on the Health of Transgender and Gender Nonconforming Populations (R01) (PA-17-478)

Sponsor:

National Institutes of Health (NIH)

Deadline:

Application Due Date(s): New Date Standard dates apply.

AIDS Application Due Date(s): New Date Standard AIDS dates apply.
Summary:

This FOA calls for research addressing the medical, sociological, psychological and structural causes and consequences of transgender and gender nonconforming identities. Investigations of the social determinants of health in these populations are needed, including understanding the impact of stigma, the high impact of HIV, minority stress, education, employment, violence, homelessness, and incarceration. More information is needed on relationships with partners and family, as well as on sexual and reproductive health. Successful aging, including the impact of life events, experiences, and interventions such as hormone therapy and surgery are other important topics to investigate. It will also be important to learn more about brain development, resilience, and end-of-life issues. Collaborative, cross disciplinary work will be essential. Areas of research sought include but are not limited to:

  • Improved Methodology and Measurement
  • Development of Transgender and Gender Nonconforming Identities
  • Improvements in Diagnosis and Clinical Management of Gender Dysphoria
  • Health Outcomes of Long-term Hormone Use and Surgical Treatment
  • Quality of Life and Mental Health

Please review the full RFP below where more details are available.

Eligibility:

Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.

Available Funding:

Application budgets are not limited but need to reflect the actual needs of the proposed project. The maximum project period is 5 years.

Link to Full RFP:

https://grants.nih.gov/grants/guide/pa-files/PA-17-478.html

CTSI’s Research Team Building Consultation Service

Sponsor:

NYU Langone Medical Center’s Clinical and Translation Science Institute

Deadline:

Rolling, but space is limited.

Summary:

The Research Team Building Consultation Service, funded through NYULMC’s CTSI mentoring program, was designed to help investigators at various stages (post docs through more senior investigators) build or enhance their team to improve research productivity while providing mentoring and training to the next generation of scholars, particularly those underrepresented in science. We help faculty/post docs build labs, design teams, and recruit over a 12-month period.

Eligibility:

No additional eligibility restrictions.

Available Funding:

Not applicable. The service will provide 15 hours of individual consultation for each investigator.

Link to Full RFP:

CTSI July 2017 Newsletter

Heineken Prizes 2018

Sponsor:

Dr H.P. Heineken Foundation and the Alfred Heineken Fondsen Foundation. The selection of the prizes is entrusted by the Royal Netherlands Academy of Arts and Sciences.

Deadline:

October 15, 2017

Summary:

The Heineken Prizes are intended explicitly for scientists and scholars who are currently active in their field and whose research still holds considerable promise for future innovative discoveries. International juries will select the winners.

Eligibility:

Prizes are available in the following fields:

Available Funding:

$200,000

Link to Full RFP:

http://www.knaw.nl/en/awards/awards/heinekenprizes/heinekenprijs-voor-de-milieuwetenschappen

MSK Lymphoma SPORE 2017-2018 Career Enhancement Program (CEP) Awards

Sponsor:
Hosted at Memorial Sloan Kettering Cancer Center – Funded by the National Institutes of Health

Deadline:

July 28, 2017

Summary:

The aim of this RFA is to identify, train and/or develop talented individuals to become successful translational investigators in the field of lymphoma. The program will support 1 or 2 individuals per year for up to two years per awardee, based on competitive renewal. Awardees will be integrated into the SPORE in order to monitor their progress and ensure successful outcome of their research projects, and will be prepared to obtain independent peer-reviewed funding.

Eligibility:

Investigators at Memorial Sloan Kettering Cancer Center, Rockefeller University, Weill Cornell Medical Center, Columbia University, Mount Sinai Hospital, and NYU, are eligible.
Funds from this program may be used to support junior faculty or established investigators who wish to enhance or refocus their careers on translational research. Eligible candidates will include individuals with the following qualifications:
a) M.D. (or D.O), PhD, or MD/PhD degree. This program is not a training program and does not support pre- or post-doctoral fellows, either pre-clinical or clinical. However, advanced post-doctoral or clinical fellows who provide a letter from an institution stating that the candidate will be joining its faculty within the year are eligible for this program.
b) Commitment to a career path in translational lymphoma research. Candidates must have demonstrated a strong aptitude for and interest in biomedical research, as evidenced by experience in the laboratory or other relevant research.
c) Exceptional clinical candidates that do not currently have an active laboratory program may also apply, provided they have a strong scientific/laboratory background, and are working with a laboratory mentor who can provide them with the necessary guidance and resources to develop a hypothesis that can be tested in the clinical setting
d) Investigators supported by NCI career development awards (K series) may also be eligible for support through this program. Investigators with previous R01 or equivalent level of funding related to lymphoma translational research are not eligible

Anticipated Funding Amount:

The program will support 1 or 2 individuals per year for up to two years per awardee, based on competitive renewal. The maximum award will be $50,000 for one year. Applicants will be funded for a maximum of two years with funding for the second year contingent on documented significant progress during the first year of funding, and peer review evaluations.

PROPOSAL PROCESS:

Proposals cannot be currently funded by an extramural agency or foundation. The budget is limited to $50K/year (direct costs. No indirect costs). Proposals must be submitted to Felicia Reid reidf@mskcc.org by July 24th, 2017.

REQUIRED INFORMATION:

Research proposals must be no longer than 5 pages (excluding budget) and should follow the format for an R01 grant application; the length of the final proposal are limited to 6 pages. The proposals will require the following standard NIH format:
Format: Applications must be in 11-point Arial. Margins must be at least 0.50 inches wide on all sides of each page.
1) Face Page (including Title, Name of Applicant, and Names of Key Collaborators)
2) Abstract (250 words max)
3) Research Plan (5-page limit). Include the following content: Specific Aims, Preliminary Studies, and Research Strategy (a. Significance, b. Innovation, c. Approach)
4) Research environment (1 page)
5) Include up to 6 Literature Citations
6) Human Subjects or Vertebrate Animals. (Please follow the NIH guidelines)
7) NIH Biosketch for all key personnel (5 pages each in NIH-specified format)
8) Budget and Budget Justification. Include a detailed NIH-format Budget for one year totaling $50,000 direct costs. The application must include a detailed budget for the initial year, a summary budget, and a budget justification.
9) The application should include a statement of long-term career goals, letter of support from the mentor with the Mentor’s CV, and 3 letters of recommendation.
REVIEW CRITERIA:
Applications will be reviewed and scored by the CEP Committee, which is composed of a diverse pool of experienced individuals with laboratory and clinical expertise. The CEP Co-Directors will assign two reviewers from the CEP Committee (one primary and one secondary reviewer) for each proposal. The initial selection will be based on the following criteria:
1. Scientific merit of the proposed project
2. Innovation
3. Approach
4. Qualifications of the investigator
5. Qualifications of the mentor
6. Research environment
IRB approval (or waiver) will be required before funding if the study involves human subjects.
SCIENTIFIC REVIEW COMMITTEE:
The CEP Co-Directors will assign two reviewers from the CEP Committee (one primary and one secondary reviewer) for each proposal.
FUNDING CYCLES:
Awards will begin in August 2017
Authors must cite the MSK Lymphoma SPORE (P50 CA192937) in the funding acknowledgements when submitting a manuscript based on research supported, in whole or in part, by this SPORE-Career Enhancement Program.
Written progress and final reports will be required at the end of funding period. Any questions regarding this solicitation should be directed to Felicia Reid reidf@mskcc.org or to the CEP directors; Dr. Riccardo Dalla Favera rd10@cumc.columbia.edu or Dr. Andrew Zelenetz Zelenetz a-zelenetz@ski.mskcc.org.
KEY DATES:
• Applications are due on July 24th, 2017
• Award Announcements by August 18th, 2017
• Award Start Date: August 30th, 2017
SUBMISSION INFORMATION:
Proposals must be submitted electronically to Felicia Reid reidf@mskcc.org. Proposals must be submitted as a compiled PDF document.
ADDITIONAL BUDGET INFORMATION:
Up to $50K direct costs for one year, may be renewable for an additional year based on review
Expenditures allowed
1 Research supplies and animal maintenance.
2 Technical assistance.
3 Publication costs, including reprints.
4 Data analysis.
5 Special fees (pathology, photography, etc.).
6 Stipends for graduate students and postdoctoral fellows.
The following expenditures will not be considered:
1 Secretary or administrative personnel.
2 Office equipment or supplies.
3 Laboratory equipment or computers.
4 Tuition.
5 Foreign travel.
6 Honoraria and travel expenditures.
7 Recruitment.
8 Patient care charges (requires justification if a clinical trial is proposed).
9 Non-medical or personal services to patients

 

MSK Lymphoma SPORE 2017-2018 Developmental Research Program (DRP) Awards

Sponsor:
Hosted at Memorial Sloan Kettering Cancer Center – Funded by the National Institutes of Health

Deadline:

July 28, 2017

Summary:

This RFA is designed to support young investigators as well as established investigators focusing on basic, translational, or clinical research of lymphoma. The primary objective of this DRP Award is to support pilot projects that explore innovative ideas in basic and translational research in lymphoma. Potential topics of interest include, but are not limited to:
• Pathogenesis
• Experimental therapeutics, including mechanism based combinations, and biomarker driven treatment strategies
• Immunology and immunotherapies
• Circulating tumor DNA

Eligibility:

Investigators at Memorial Sloan Kettering Cancer Center, Rockefeller University, Weill Cornell Medical Center, Columbia University, Mount Sinai Hospital, and NYU, are eligible.
Applicants must hold academic rank of Instructor, Assistant Professor, or higher.
Applicants must possess an MD, DO or a PhD degree in a relevant area of research. The pilot projects may be collaborative among scientists within one or more SPOREs, or with scientists outside the SPORE community including the international scientific community. High risk/high payoff pilot projects are especially encouraged. These pilot projects do not need to reach a human endpoint during the project period as do full projects, including the Developmental Research Program. Letters of collaboration (if if applicable)

Proposals cannot be currently funded by an extramural agency or foundation. The budget is limited to $50K/year (direct costs. No indirect costs).

Anticipated Funding Amount:

Each year, 3-4 applications will be funded. The maximum award will be $50,000 for one year. Applicants will be funded for a maximum of two years with funding for the second year contingent on documented significant progress during the first year of funding, and peer review evaluations.

PROPOSAL PROCESS:

Proposals cannot be currently funded by an extramural agency or foundation. The budget is limited to $50K/year (direct costs. No indirect costs). Proposals must be submitted to Felicia Reid reidf@mskcc.org by July 24th, 2017.

REQUIRED INFORMATION:
Research proposals must be no longer than 5 pages (excluding budget) and should follow the format for an R01 grant application; the length of the final proposal are limited to 6 pages. The proposals will require the following standard NIH format:
Format: Applications must be in 11-point Arial. Margins must be at least 0.50 inches wide on all sides of each page.
MSK Lymphoma SPORE
2017-2018 Developmental Research Program (DRP) Awards
1) Face Page (including Title, Name of Applicant, and Names of Key Collaborators)
2) Abstract (250 words max)
3) Research Plan (5-page limit). Include the following content: Specific Aims, Preliminary Studies, and Research Strategy (a. Significance, b. Innovation, c. Approach)
6) Research environment (1 page)
7) Include up to 6 Literature Citations
8) Human Subjects or Vertebrate Animals. (Please follow the NIH guidelines)
9) NIH Biosketch for all key personnel (5 pages each in NIH-specified format)
10) Budget and Budget Justification. Include a detailed NIH-format Budget for one year totaling $50,000 direct costs. The application must include a detailed budget for the initial year, a summary budget, and a budget justification.
REVIEW CRITERIA:
All proposals will be reviewed by the scientific review committee and ad hoc reviewers, according to the following criteria, as relevant:
1. Scientific merit of the proposed project
2. Innovation
3. Approach
4. Qualifications of the investigator
5. Research environment
IRB approval (or waiver) will be required before funding if the study involves human subjects.
SCIENTIFIC REVIEW COMMITTEE:
The DRP Review Committee will include 3 ad hoc members of the SPORE Internal Advisory Board Committee, and 3 ad hoc members of the SPORE External Advisory Board Committee, and 3 additional external reviewers from other lymphoma SPORES
FUNDING CYCLES:
Awards will begin in August 2017
Authors must cite the MSK Lymphoma SPORE (P50 CA192937) in the funding acknowledgements when submitting a manuscript based on research supported, in whole or in part, by this SPORE-Developmental Research Program.
Written progress and final reports will be required at the end of funding period. Any questions regarding this solicitation should be directed to Felicia Reid reidf@mskcc.org or to the DRP directors; Dr. John Leonard jpleonar@med.cornell.edu or Dr. Anas Younes younesa@mskcc.org.
KEY DATES:
• Applications are due on July 24th, 2017
• Award Announcements by August 18th, 2017
• Award Start Date: August 30th, 2017

SUBMISSION INFORMATION:
Proposals must be submitted electronically to Felicia Reid reidf@mskcc.org. Proposals must be submitted as a compiled PDF document.
ADDITIONAL BUDGET INFORMATION: Up to $50K direct costs for one year, may be renewable for an additional year based on review
Expenditures allowed
1 Research supplies and animal maintenance.
2 Technical assistance.
3 Publication costs, including reprints.
4 Data analysis.
5 Special fees (pathology, photography, etc.).
6 Stipends for graduate students and postdoctoral fellows.
The following expenditures will not be considered:
1 Secretary or administrative personnel.
2 Office equipment or supplies.
3 Laboratory equipment or computers.
4 Tuition.
5 Foreign travel.
6 Honoraria and travel expenditures.
7 Recruitment.
8 Patient care charges (requires justification if a clinical trial is proposed).
9 Non-medical or personal services to patients.

Socioeconomic Disparities in Health and Mortality at Older Ages (R01) (RFA-AG-18-011)

Sponsor:

National Institute on Aging

Deadline:

October 20, 2017

Summary:

The purpose of this funding opportunity is to support studies that identify mechanisms, explanations, and modifiable risk factors underlying recent trends of growing inequalities in morbidity and mortality by income, education, and geographic location at older ages in the United States. Applicants are encouraged to consider a variety of health outcomes in order to explain the processes generating these trends. Applicants are strongly encouraged to present well-developed conceptual models.

Examples of analytic approaches that fall within the scope of this FOA include (but are not limited to) those that:

  • Identify the mechanisms that explain growing socioeconomic and geographic inequalities in health at older ages, explain their role in racial disparities, and detect modifiable risk factors
  • Ascertain the extent to which these trends are driven by age, period, and cohort-related factors
  • Consider the role of education, income, and geographic region as causal factors versus alternative explanations such as differential selection over time or shifting composition of groups
  • Leverage longitudinal data, ideally from childhood through old age
  • Use a diverse set of analytic methods (e.g. life-cycle, comparative, cohort, multi-level)
  • Consider how institutional and cultural contexts (including their timing within the life course of individuals) influence health disparities
  • Examine a wide range of physical, mental, and functional health outcomes, in addition to mortality
  • Capitalize on NIA-funded data sources with life history and geographic information (e.g., English Longitudinal Study of Ageing; Health and Retirement Study; Midlife in the United States; National Longitudinal Mortality Study; Panel Study of Income Dynamics; Survey of Health, Ageing, and Retirement in Europe)

Examples of data improvements that fall within the scope of this FOA include (but are not limited to) those that:

  • Enhance existing data resources to improve data availability on a variety of topics (e.g., early life development, exposures to inequality prior to midlife, comprehensive stress measurements, employer and work issues, and minority groups) to enable examination of within-group heterogeneity
  • Enhance existing clinical studies to add complementary measures in areas such as social, emotional, and psychological domains

Characteristics of Responsive Applications

1. Life course approaches are encouraged, but applications proposing analysis of data solely from childhood or young adulthood are not responsive to this FOA.

2. Applications that document descriptive trends without assessing potential mechanisms or explanations will not be considered responsive.

3. Applications proposing projects that use only animal models are not responsive to this FOA. 

Eligibility:

Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.

For institutions/organizations proposing multiple PDs/PIs, visit the Multiple Program Director/Principal Investigator Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the SF424 (R&R) Application Guide.

Available Funding:

The National Institute on Aging intends to commit $2 million in total costs in FY 2018 to fund 3-6 awards. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Link to Full RFP:

https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-18-011.html

Multi-discipline and Systemic Caring for the Woman Experiencing Menopause: Innovative Decision Making Tools

Sponsor:

Pfizer Independent Grants for Learning & Change

Deadline:

July 12, 2017

Summary:

Pfizer Global Medical Grants seeks to support innovative educational programming to support optimal and/or appropriate practice interventions regarding care and treatment of women experiencing menopause. Projects should focus on educational resources (e.g. patient-physician shared decision-making tools /innovative apps) to support effective identification of the need for therapeutic intervention and appropriate selection of therapeutic intervention based on presentation.

  • The learning and change strategy should address helping improve the care of women with menopause by:
  • Improving symptom identification (by patients or physicians)
  • Improving care systems that showcase and operationalize the wellness visit as a focus for menopausal care

Innovating patient-physician awareness of various treatment options and modalities for appropriate patients and with appropriate risk-balance assessment The educational initiative should be focused on primary care practitioners, nurse practitioners, physician assistants, obstetricians and gynecologists, and all other specialists who care for the menopausal woman. Proposals whose educational model is broadly applicable for use in other settings and/or used for resident education will be rated favorably.

In addition, proposals that include the following elements are of interest:

  • Completed within a 12 month timeframe
  • Developing durable tools, materials (e.g. >1 one time use)
  • Intraprofessional collaboration among organizations
  • Incorporating the patient perspective
  • Innovative in terms of approach and output
  • Robust outcomes plan that reflects optimization of care metrics

The utilization of multiple forms of innovation, such as digital communication or social media, to reach the intended audience and to measure change in comprehension and intent to apply learning in practice are critical parts of a successful grant.

Projects that focus on live annual meetings, regional conferences, and speaker series are out of scope.

Eligibility:

Project  must be based in the United States.

The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.

Collaborations within institutions (e.g., between departments and/or inter-professional), as well as between different institutions/organizations/associations, or even different disciplines are encouraged. All partners must have a relevant role, and the requesting organization must have a leadership role.

Available Funding:

Individual projects requesting up to $200,000 will be considered.

Link to Full RFP:

http://www.pfizer.com/files/IGLC_CGA17WH2_MenopausalCare.v.2.pdf

Addressing Attitudes, Beliefs, and Cultural Barriers in Women’s Health Decision-Making

Sponsor:

Pfizer Independent Grants for Learning & Change (IGLC)

Deadline:

July 26, 2017

Summary:

Pfizer Global Medical Grants seeks to support innovative educational programming to understand the role of patient attitudes, beliefs, and cultural barriers in women’s health decision-making during reproductive and post-reproductive health care. These factors have a major influence and variations exist globally for women during life events including family planning and menopause related issues. The learning and change strategy should address techniques to overcome barriers in improving the care of women during family planning and/or menopause by:

  • Improving care systems that showcase and operationalize the wellness visit
  • Innovating the patient-physician dialogue (e.g. ‘difficult conversations’)
  • Innovating patient-physician awareness of various treatment options and modalities for appropriate patients and with appropriate risk-balance assessment
  • Dispelling common patient myths and misconceptions.

The educational initiative should be focused on primary care practitioners including general practitioners, nurse practitioners, physician assistants, obstetricians and gynecologists, and/or other specialists who care for women in the reproductive phase of their lives, menopausal women, or all. Proposals whose educational model is broadly applicable for use in varied settings and/or used for trainee education will be rated favorably.

The utilization of multiple forms of innovation, such as digital communication or social media, to reach the intended audience and to measure change in comprehension and intent to apply learning in practice are critical parts of a successful grant.  

Eligibility:

Project must be global in scope.

The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.

Collaborations within institutions (e.g., between departments and/or inter-professional), as well as between different institutions/organizations/associations, or even different disciplines are encouraged. All partners must have a relevant role, and the requesting organization must have a leadership role.

Available Funding:

Individual projects requesting up to $200,000 will be considered.

Link to Full RFP:

http://www.pfizer.com/files/IGLC_CGA17WH1_WomensHealth.v.2.pdf

Addressing Education in Relation to Tobacco Dependence Treatment in France

Sponsor:

Pfizer Independent Grants for Learning & Change (IGLC)

Deadline:

July 31, 2017

Summary:

It is our intent to support programs that strive to increase the number of patients who stop smoking by improving the frequency and effectiveness of healthcare professional smoking cessation interventions. This CGA is to encourage academic and healthcare organisations to submit applications focused on educating healthcare professionals on the latest clinical data-driven updates in tobacco dependence treatments. Applications focusing on one or more of the following criteria will be given preference:

  • Educating physicians to initiate smoking cessation discussions with patients and to promote the health benefits of smoking cessation
  • Educating physicians about the importance of initiating smoking cessation therapy
  • Increasing physician awareness of the available treatment and support mechanisms required for smoking cessation
  • Educating physicians about the importance of ensuring appropriate follow-up with patients following initiation of smoking cessation treatment/counselling to ensure compliance

While programming targeted at addressing knowledge gaps may involve live sessions, efforts should be made to encourage interaction and provide opportunities to extend learning opportunities beyond the live setting. In addition to live programs, technology-enabled distance learning with facilitated interactive components, online courses, and other enduring materials may also be proposed.

Eligibility:

Geographic scope is France only.

The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement. However, please note that priority will be given to applications from non-profit academic and healthcare organisations.

Collaborations within institutions (e.g., between departments and/or inter-professional), as well as between different institutions/organizations/associations, or even different disciplines are encouraged. All partners must have a relevant role, and the requesting organization must have a leadership role.

Available Funding:

Individual projects requesting up to $50,000 will be considered. The total available budget related to this CGA is $150,000.

Link to Full RFP:

http://www.pfizer.com/files/IGLC_CGA17SC1_SmokingCessation.pdf